The Insight-Adherence-Abstinence triad: An integrated treatment focus for cannabis-using first-episode schizophrenia patients

Bulletin of the Menninger Clinic

Volumn 69, Issue 3, 2005, Pages 220-236

  Miller, Rachel ^a,b   Caponi, Joanne McCormack ^a   Sevy, Serge ^a,c   Robinson, Delbert ^a,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ADELPHI UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ABSTINENCE; ADULT; BEHAVIOR THERAPY; CANNABIS ADDICTION; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITIVE THERAPY; CONVALESCENCE; DENIAL; FEMALE; GROUP THERAPY; HUMAN; LONG TERM CARE; MALE; MENTAL PATIENT; MOTIVATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOTHERAPY; RELAPSE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SKILL; SUPPORT GROUP;

COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MOTIVATION; PATIENT COMPLIANCE; SCHIZOPHRENIA;

EID: 28444451234     PISSN: 00259284     EISSN: 00259284     Source Type: Journal    
DOI: 10.1521/bumc.2005.69.3.220     Document Type: Review

References (35)

1. Addington, J., & Addington, D. (1998). Effect of substance misuse in early psychosis. British Journal of Psychiatry, 172, 134-136.
2. Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal, 25, 60-66.
3. Bartels, S.J., Teague, G.B., Drake, R.E., Clark, R.E., Bush, P.W., & Noordsy, D.L. (1993). Substance abuse in schizophrenia: Service utilization and costs. Journal of Nervous and Mental Disease, 181, 227-232.
4. Beisel, J. R., Scott, J., & Dixon, L. (1999). Co-occurring severe mental illness & substance use disorders. Psychiatric Services, 50, 1427-1434.
5. Bellack, A.S., Bennett, M.E., & Gearon, J.S. (2003). Behavioral treatment for substance abuse in schizophrenia (BTSAS): A training manual for mental health professionals. Baltimore: University of Maryland School of Medicine.
6. Bellack, A.S., & DiClemente, C. C. (1999). Treating substance abuse among patients with schizophrenia. Psychiatric Services, 50, 75-80.
7. Bottlender, R., Sato, T., Jager, M., Groll, C., Strauss, A., & Moller, H.J. (2002). The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenia and schizoaffective patients. European Archives of Psychiatry and Clinical Neuroscience, 252, 226-231.
8. Buhler, B., Hambrecht, M., Loffler, W., Heiden, W., & Hafner, H. (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse - A retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research, 54, 243-251.
9. Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: Prevalence impact on outcomes. Schizophrenia Research, 35 (suppl.) S93-S100.
10. First, M.B., Spitzer, R.L., Gibbon, M., & Williams, J.B. (1998). Structured clinical interview for DSM-IV axis I disorders-Patient edition (SCID-I/P, Version 2.0, 8/98 revision). New York, Biometrics Research Department.
11. Green, A.I., Tohen, M.F., Hamer, R.M., Strakowski, S.M., Lieberman, J.A., Glick, I., & et al. (2004). First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol. Schizophrenia Research, 66, 125-135.
12. Gupta, S., Hendricks, S., Kenkel, A., Bhatia, S., & Haffke, E. (1996). Relapse in schizophrenia: Is there a relationship to substance abuse? Schizophrenia Research, 20, 153-156.
13. Hinton, M., Elkins, K., Edwards, J., & Donovan, K. (2002). Cannabis and psychosis: An early psychosis treatment manual. Parkville VIC, Australia: Early Psychosis Prevention and Intervention Centre.
14. Hughs, I., Hill, B., & Budd, R. (1997). Compliance with antipsychotic medication: From theory to practice. Journal of Mental Health, 6, 473-489.
15. Kemp, R., Hayward, P, Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: Randomised controlled trial. British Medical Journal, 312, 345-349.
16. Larsen, T.K., Johannessen, J.O., & Opjordsmoen, S. (1998). First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. British Journal of Psychiatry Supplement, 172, 45-52.
17. Lewis, L. (2004). Mourning, insight, and reduction of suicide risk in schizophrenia. Bulletin of the Menninger Clinic, 68, 231-244.
18. Linszen, D.H., Dingermans, P.M., & Lenior, M.E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279.
19. Linszen, D.H., Dingermans, P.M., & Lenior, M.E. (2001). Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: Ethical implications. Schizophrenia Research, 51, 55-61.
20. Miller, R., & Mason, S.E. (1999). Phase-specific treatment for first-episode schizophrenia. Bulletin of the Menninger Clinic, 63, 499-519.
21. Miller, R., & Mason, S.E. (2002). Diagnosis: Schizophrenia. New York: Columbia University Press.
22. Miller, R., & Mason, S.E. (2004). Cognitive enhancement therapy: A therapeutic treatment strategy for first-episode schizophrenia patients. Bulletin of the Menninger Clinic, 68, 213-230.
23. Minkoff, K. (2001). Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Services, 52, 597-599.
24. Mueser, K.T., Noordsy, D.L., Drake, R.E., & Fox, L. (2003). Integrated treatment for dual disorders. New York: Guilford Press.
25. Prochaska, J.O., DiClemente, C.D., & Norcross, J.C. (1992). In search of how people change: Applications to addictive behaviors. American Psychologist, 47, 1102-1114.
26. Robinson, D.G., Woerner, M.G., Alvir, J.M., Geisler, S., Koreen A., Sheitmen, B., et al. (1999). Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 156, 544-549.
27. Sevy, S., Robinson, D.G., Holloway, S., Alvir, J., Woerner, M.G., Bilder, R., et al. (2001). Correlates of substance misuse inpatients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 104, 367-374.
28. Smith, J., & Hucker, S. (1994). Schizophrenia and substance abuse. British Journal of Psychiatry, 165, 13-21.
29. Valasquez, M.M., Maurer, G.G., Crouch, C., & DiClemente, C.C. (2001). Group treatment for substance abuse. New York: Guilford Press.
30. Van Mastrigt, S., Addington, J., & Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry Psychiatric Epidemiology, 39, 69-72.
31. Wallace, C., Mullen, P.E., & Burgess, P. (2004). Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. American Journal of Psychiatry, 161, 716-727.
32. Weiden, P. J., Scheifler, P. L., McEvoy, J. P., Frances, A., & Ross, R. (1999). Expert consensus treatment guidelines for schizophrenia: A guide for patients and families. Journal of Clinical Psychiatry, 60, 1-8.
33. Ziedonis, D.M., & D'Avanzo, K. (1998). Schizophrenia and substance abuse. In H.R. Kranzler & B.J. Rounsaville (Eds.), Dual diagnosis and treatment: Substance abuse and comorbid medical and psychiatric disorders (pp. 427-465). New York: Marcel Dekker.
34. Ziedonis, D.M. & Trudeau, K. (1997). Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based model. Schizophrenia Bulletin, 23, 229-238.
35. Zisook, S., Heaton, R., Moranville, J., Kuck, J., Jernigan, T., & Braff, D. (1992). Past substance abuse and clinical course in schizophrenia. Clinical and Research Reports, 149, 552-553.